These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 10200806)

  • 21. Maintenance of Pseudomonas antibiotic sensitivity in patients with cystic fibrosis treated with inhaled antibiotics.
    Wittenberg DF
    S Afr Med J; 1987 Mar; 71(5):335-6. PubMed ID: 3563765
    [No Abstract]   [Full Text] [Related]  

  • 22. Long-Term Inhaled Antipseudomonal Antibiotics in Cystic Fibrosis.
    Greenslade R
    Am J Nurs; 2019 Oct; 119(10):49. PubMed ID: 31567255
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Azithromycin in cystic fibrosis.
    Kastelik JA; Peckham DG; Conway S
    Eur Respir J; 2005 Apr; 25(4):771; author reply 771-2. PubMed ID: 15802355
    [No Abstract]   [Full Text] [Related]  

  • 24. Pharmacokinetics of antibiotics in cystic fibrosis patients with particular reference to the bronchopulmonary tree (review).
    Bergogne-Berezin E
    Infection; 1987; 15(4):288-94. PubMed ID: 3312023
    [No Abstract]   [Full Text] [Related]  

  • 25. A formulation of aerosolized tobramycin (Bramitob) in the treatment of patients with cystic fibrosis and Pseudomonas aeruginosa infection: a double-blind, placebo-controlled, multicenter study.
    Chuchalin A; Csiszér E; Gyurkovics K; Bartnicka MT; Sands D; Kapranov N; Varoli G; Monici Preti PA; Mazurek H
    Paediatr Drugs; 2007; 9 Suppl 1():21-31. PubMed ID: 17536872
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pseudomonas eradication in cystic fibrosis: who will join the ELITE?
    Smyth AR
    Thorax; 2010 Apr; 65(4):281-2. PubMed ID: 20388748
    [No Abstract]   [Full Text] [Related]  

  • 27. Intermittent administration of inhaled tobramycin in patients with cystic fibrosis.
    Hazinski TA
    J Pediatr; 1999 Jul; 135(1):130. PubMed ID: 10428654
    [No Abstract]   [Full Text] [Related]  

  • 28. Cystic fibrosis upper airways primary colonization with Pseudomonas aeruginosa: eradicated by sinonasal antibiotic inhalation.
    Mainz JG; Michl R; Pfister W; Beck JF
    Am J Respir Crit Care Med; 2011 Nov; 184(9):1089-90. PubMed ID: 22045752
    [No Abstract]   [Full Text] [Related]  

  • 29. [Ochrobactrum anthropi bacteremia in a child with cystic fibrosis].
    Yagüe-Muñoz A; Gregori-Roig P; Valls-López S; Pantoja-Martínez J
    Enferm Infecc Microbiol Clin; 2010 Feb; 28(2):137-8. PubMed ID: 19811858
    [No Abstract]   [Full Text] [Related]  

  • 30. [Antibiotics and nebulization].
    Diot P
    Arch Pediatr; 1999; 6 Suppl 2():169s-171s. PubMed ID: 10370468
    [No Abstract]   [Full Text] [Related]  

  • 31. [Detection and management of early Pseudomonas aeruginosa infection in patients with cystic fibrosis].
    Kernen Y; Sauty A; Roulet M
    Rev Med Suisse; 2005 Mar; 1(9):637-8, 640. PubMed ID: 15813341
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tobramycin inhalation powder (Tobi Podhaler) for cystic fibrosis.
    Med Lett Drugs Ther; 2013 Jun; 55(1419):51-2. PubMed ID: 23797798
    [No Abstract]   [Full Text] [Related]  

  • 33. Home intravenous antibiotic treatment in cystic fibrosis.
    Gilbert J; Robinson T; Littlewood JM
    Arch Dis Child; 1988 May; 63(5):512-7. PubMed ID: 3389866
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanism of action of antibiotics in chronic pulmonary pseudomonas infection.
    Høiby N; Giwercman B; Jensen ET; Pedersen SS; Koch C; Kharazmi A
    Adv Pharmacol; 1994; 30():53-84. PubMed ID: 7833297
    [No Abstract]   [Full Text] [Related]  

  • 35. Pulmonary infection and antibiotic treatment in patients with cystic fibrosis.
    Kerrebijn KF; Mouton J
    Acta Univ Carol Med (Praha); 1990; 36(1-4):28-33. PubMed ID: 2130712
    [No Abstract]   [Full Text] [Related]  

  • 36. Early Pseudomonas aeruginosa colonisation in cystic fibrosis patients.
    Marchetti F; Candusso M; Faraguna D; Assael BM
    Lancet; 2002 Feb; 359(9306):626-7. PubMed ID: 11867141
    [No Abstract]   [Full Text] [Related]  

  • 37. Aztreonam inhalation solution for suppressive treatment of chronic Pseudomonas aeruginosa lung infection in cystic fibrosis.
    Assael BM
    Expert Rev Anti Infect Ther; 2011 Nov; 9(11):967-73. PubMed ID: 22029514
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [TOBI Podhaler for treating chronic Pseudomonas aeruginosa infection in cystic fibrosis patients].
    Pierart F
    Rev Med Liege; 2013 Sep; 68(9):486-8. PubMed ID: 24180205
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dry powder inhalation versus wet nebulisation delivery of antibiotics in cystic fibrosis patients.
    Westerman EM; Heijerman HG; Frijlink HW
    Expert Opin Drug Deliv; 2007 Mar; 4(2):91-4. PubMed ID: 17335406
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Approach to Pseudomonas aeruginosa in Cystic Fibrosis.
    Talwalkar JS; Murray TS
    Clin Chest Med; 2016 Mar; 37(1):69-81. PubMed ID: 26857769
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.